The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
Identifieur interne : 000120 ( Main/Exploration ); précédent : 000119; suivant : 000121The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
Auteurs : Brenda D. Jamerson [États-Unis] ; T Ho Haryadi [États-Unis]Source :
- Medical hypotheses [ 1532-2777 ] ; 2020.
Abstract
Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness.
DOI: 10.1016/j.mehy.2020.109880
PubMed: 32505846
PubMed Central: PMC7247463
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?</title><author><name sortKey="Jamerson, Brenda D" sort="Jamerson, Brenda D" uniqKey="Jamerson B" first="Brenda D" last="Jamerson">Brenda D. Jamerson</name><affiliation wicri:level="2"><nlm:affiliation>Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710. USA; Center on Health and Society, Duke University, Durham, NC, USA. Electronic address: bjamers@gmail.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710. USA; Center on Health and Society, Duke University, Durham, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Haryadi, T Ho" sort="Haryadi, T Ho" uniqKey="Haryadi T" first="T Ho" last="Haryadi">T Ho Haryadi</name><affiliation wicri:level="2"><nlm:affiliation>Hillsborough, NC 27278, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hillsborough, NC 27278</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32505846</idno><idno type="pmid">32505846</idno><idno type="doi">10.1016/j.mehy.2020.109880</idno><idno type="pmc">PMC7247463</idno><idno type="wicri:Area/Main/Corpus">000646</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000646</idno><idno type="wicri:Area/Main/Curation">000646</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000646</idno><idno type="wicri:Area/Main/Exploration">000646</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?</title><author><name sortKey="Jamerson, Brenda D" sort="Jamerson, Brenda D" uniqKey="Jamerson B" first="Brenda D" last="Jamerson">Brenda D. Jamerson</name><affiliation wicri:level="2"><nlm:affiliation>Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710. USA; Center on Health and Society, Duke University, Durham, NC, USA. Electronic address: bjamers@gmail.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710. USA; Center on Health and Society, Duke University, Durham, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Haryadi, T Ho" sort="Haryadi, T Ho" uniqKey="Haryadi T" first="T Ho" last="Haryadi">T Ho Haryadi</name><affiliation wicri:level="2"><nlm:affiliation>Hillsborough, NC 27278, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hillsborough, NC 27278</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author></analytic><series><title level="j">Medical hypotheses</title><idno type="eISSN">1532-2777</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32505846</PMID><DateRevised><Year>2020</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2777</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><PubDate><Year>2020</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>Medical hypotheses</Title><ISOAbbreviation>Med. Hypotheses</ISOAbbreviation></Journal><ArticleTitle>The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?</ArticleTitle><Pagination><MedlinePgn>109880</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0306-9877(20)30948-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mehy.2020.109880</ELocationID><Abstract><AbstractText>Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jamerson</LastName><ForeName>Brenda D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710. USA; Center on Health and Society, Duke University, Durham, NC, USA. Electronic address: bjamers@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haryadi</LastName><ForeName>T Ho</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Hillsborough, NC 27278, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Hypotheses</MedlineTA><NlmUniqueID>7505668</NlmUniqueID><ISSNLinking>0306-9877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32505846</ArticleId><ArticleId IdType="pii">S0306-9877(20)30948-8</ArticleId><ArticleId IdType="doi">10.1016/j.mehy.2020.109880</ArticleId><ArticleId IdType="pmc">PMC7247463</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Caroline du Nord</li></region></list><tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Jamerson, Brenda D" sort="Jamerson, Brenda D" uniqKey="Jamerson B" first="Brenda D" last="Jamerson">Brenda D. Jamerson</name></region><name sortKey="Haryadi, T Ho" sort="Haryadi, T Ho" uniqKey="Haryadi T" first="T Ho" last="Haryadi">T Ho Haryadi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000120 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000120 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32505846
|texte= The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32505846" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |